The aim of this study is to evaluate the feasibility and effectiveness of a remote personalised lifestyle program in individuals with T2D. Outcomes will be assessed at the start and after 3, 6, and 12 months with two follow-up measurements (18 and 24 months) to determine whether participation in this re-mote lifestyle program leads to improvements in health and diabetes-related outcomes.
Age: ≥18 years
HbA1c: ≥53 mmol/mol (7 - 12%)
Signed informed consent form and willing to comply with the study procedures
Persons who are naïve for participation in a lifestyle program for the past two years
Medication use: any other glucose-lowering medication than metformin
Comorbidities or medical conditions requiring a special diet that conflicts with the study
Unstable body weight in the three months prior to inclusion in the study (±5% change based on body weight)
Circumstances that lead to unreliable HbA1c values, such as blood donation
University of Twente
Lead sponsor
TNO
Collaborator